lmatinib Mesylate (α form)

lmatinib Mesylate (α form)

Home
Products
APIs
Main Products
Oncology
lmatinib Mesylate (α form)

Products

Contact Us

We are here to help in anything you need. Please use our online system or send an email to .

lmatinib Mesylate (α form)

Inquiry

Catalog Number	PR220127571-1
CAS	220127-57-1
Structure
Description	Imatinib Mesylate is the mesylate salt of imatinib, a tyrosine kinase inhibitor with antineoplastic activity. Imatinib binds to an intracellular pocket located within tyrosine kinases (TK), thereby inhibiting ATP binding and preventing phosphorylation and the subsequent activation of growth receptors and their downstream signal transduction pathways.
Synonyms	Gleevec; Glivec; Imatinib mesilate
IUPAC Name	methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Molecular Weight	589.7
Molecular Formula	C30H35N7O4S
InChI	YLMAHDNUQAMNNX-UHFFFAOYSA-N
InChI Key	InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)
Isomeric SMILES	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Therapeutic Category	Oncology

It should be noted that our service is only used for research, not for clinical use.